促销时间表 UroGen Pharma Ltd.
先进的时间表
简单图表
关于公司
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. 更多详情IPO date | 2017-05-04 |
---|---|
ISIN | IL0011407140 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.urogen.com |
Цена ао | 15.17 |
每日价格变化: | -2.54% (11.04) |
---|---|
每周价格变化: | +1.13% (10.64) |
每月价格变化: | -15.01% (12.66) |
3个月内价格变化: | -16.59% (12.9) |
六个月内的价格变化: | -28.93% (15.14) |
每年价格变化: | -28.27% (15) |
3年内价格变化: | +13.74% (9.46) |
5年内价格变化: | -65.05% (30.79) |
10年价格变化: | 0% (10.76) |
年初以来价格变化: | -12.8% (12.34) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
机构 | 体积 | 分享, % |
---|---|---|
Great Point Partners LLC | 2620545 | 8.49 |
Menora Mivtachim Holdings Ltd. | 2303031 | 7.46 |
RA Capital Management, L.P. | 1483697 | 4.81 |
Blackrock Inc. | 1197647 | 3.88 |
Credit Suisse Ag/ | 1060000 | 3.43 |
Harel Insurance Investments & Financial Services Ltd. | 870194 | 2.82 |
RTW Investments LP | 857464 | 2.78 |
Migdal Insurance & Financial Holdings Ltd. | 648302 | 2.1 |
SILVERARC CAPITAL MANAGEMENT, LLC | 508883 | 1.65 |
Wildcat Capital Management, LLC | 495606 | 1.61 |
ETF | 分享, % | 本年盈利能力, % | 股息, % |
---|---|---|---|
ARK Israel Innovative Technology ETF | 1.67779 | 24.64 | 1.21688 |
Amplify BlueStar Israel Technology ETF | 0.57399 | 20.42 | 0.47569 |
iShares Micro-Cap ETF | 0.12986 | 17.09 | 1.54048 |
Future Tech ETF | 0.05533 | 426.34 | 0.8416 |
Principal Healthcare Innovators ETF | 0.05533 | 618.5 | 0.8416 |
Invesco Nasdaq Biotechnology ETF | 0.04838 | 28.58 | 0.8565 |
ProShares Ultra Nasdaq Biotechnology | 0.03147 | 51.7 | 0.85651 |
SPDR S&P International Small Cap ETF | 0.03065 | 8.94 | 3.10348 |
Vanguard Russell 2000 Growth ETF | 0.03 | 23.05 | 0.60264 |
iShares Russell 2000 Growth ETF | 0.02916 | 38.04 | 0.6026 |
Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02471 | 31.36 | 1.41955 |
Vanguard Russell 2000 ETF | 0.02 | 17.16 | 1.48801 |
ProShares UltraPro Russell2000 | 0.01005 | 89.82 | 1.47873 |
SPDR Portfolio Developed World ex-US ETF | 0.00776 | 5.29 | 3.28401 |
Fidelity MSCI Health Care Index ETF | 0.00575 | 3 | 1.46057 |
ProShares Hedge Replication ETF | 0.00273 | 5.92 | 1.47892 |
iShares Russell 3000 ETF | 0.00087 | 24.83 | 1.43482 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Ms. Elizabeth A. Barrett | President, CEO & Director | 1.12M | 1962 (63 年) |
Mr. Dong Kim | Chief Financial Officer | 546.68k | 1977 (48 年) |
Mr. Jason Drew Smith | General Counsel, Chief Compliance Officer & Corporate Secretary | 717.58k | 1972 (53 年) |
Vincent I. Perrone | Senior Director of Investor Relations | N/A | |
Mr. Bryon Wornson | Executive Vice President of Talent, Advocacy & Communications | N/A | |
Dr. Mark P. Schoenberg M.D. | Chief Medical Officer | 579.5k | 1958 (67 年) |
Mr. James Ottinger R.ph. | Executive Vice President of Regulatory Affairs & Quality | N/A | |
Dr. Marina Konorty Ph.D. | Executive Vice President of Research & Development and Technical Operations | ||
Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D. | Chief Business Officer | 1965 (60 年) | |
Mr. Michael J. Louie M.D., M.P.H., M.Sc. | Senior Vice President of Medical Affairs & Clinical Development |
地址: United States, Princeton. NJ, 400 Alexander Park - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.urogen.com
网站: https://www.urogen.com